Related references
Note: Only part of the references are listed.Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues
Grace L-H Wong et al.
ANTIVIRAL THERAPY (2013)
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
Danny Ka-Ho Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Off-Therapy Durability of Response to Entecavir Therapy in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
Wen-Juei Jeng et al.
HEPATOLOGY (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Reduction of Hepatitis B Surface Antigen Levels and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients Receiving 10 Years of Nucleoside Analogue Therapy
Wai-Kay Seto et al.
HEPATOLOGY (2013)
Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment
Wai-Kay Seto et al.
JOURNAL OF HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Two-step evolution of the hepatitis B drug-resistant mutations in a patient who developed primary entecavir resistance
Guan-Huei Lee et al.
LIVER INTERNATIONAL (2013)
Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2012)
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
Tai-Chung Tseng et al.
HEPATOLOGY (2012)
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance
Wai-Kay Seto et al.
HEPATOLOGY (2012)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
Y. Liang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
Henry L-Y Chan et al.
ANTIVIRAL THERAPY (2011)
Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
Nghiem B. Ha et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients
Feng Liu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy
James Fung et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis B surface antigen quantification: Why and how to use it in 2011-A core group report
Henry Lik-Yuen Chan et al.
JOURNAL OF HEPATOLOGY (2011)
Viral Determinants of Hepatitis B Surface Antigen Seroclearance in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients
Henry Lik-Yuen Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: Virological breakthrough is also dependent on adherence to medication
Hidehiro Kamezaki et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Nucleos(t)ide Analogues Only Induce Temporary Hepatitis B e Antigen Seroconversion in Most Patients With Chronic Hepatitis B
Jurrien G. P. Reijnders et al.
GASTROENTEROLOGY (2010)
Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
Maurizia Rossana Brunetto et al.
GASTROENTEROLOGY (2010)
A Longitudinal Study on the Natural History of Serum Hepatitis B Surface Antigen Changes in Chronic Hepatitis B
Henry Lik-Yuen Chan et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers: Disease Phase Influences Correlation with Viral Load and Intrahepatic Hepatitis B Virus Markers
Alexander J. V. Thompson et al.
HEPATOLOGY (2010)
The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion
James Fung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
Daniel Shouval et al.
JOURNAL OF HEPATOLOGY (2009)
Characteristics of patients with chronic hepatitis B in France: Predominant frequency of HBe antigen negative cases
Jean-Pierre Zarski et al.
JOURNAL OF HEPATOLOGY (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy
J Summers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
